ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,318.00
      0.95%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      82.845
      1.06%
      Bitcoin
      70,161.52
      2.41%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Tyra Biosciences Inc (TYRA)

      7. Tyra Biosciences Inc (TYRA) News

      TYRA

      Tyra Biosciences (TYRA)

      Tyra Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TYRA
      DateTimeSourceHeadlineSymbolCompany
      05/23/20244:05PMPR Newswire (US)Tyra Biosciences to Present at Upcoming Investor ConferencesNASDAQ:TYRATyra Biosciences Inc
      05/09/20244:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      05/09/20244:46PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      05/09/20244:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TYRATyra Biosciences Inc
      05/09/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
      05/09/20244:05PMPR Newswire (US)Tyra Biosciences Reports First Quarter 2024 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
      05/07/20244:34PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TYRATyra Biosciences Inc
      05/07/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
      05/07/20244:05PMPR Newswire (US)Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of DirectorsNASDAQ:TYRATyra Biosciences Inc
      03/19/20244:05PMPR Newswire (US)Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
      03/08/20245:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      03/05/20245:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/29/20246:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/27/20244:05PMPR Newswire (US)Tyra Biosciences to Present at Upcoming Investor ConferencesNASDAQ:TYRATyra Biosciences Inc
      02/14/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/13/20244:36PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:TYRATyra Biosciences Inc
      02/12/20244:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/09/20247:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/07/20244:05PMPR Newswire (US)Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences ConferenceNASDAQ:TYRATyra Biosciences Inc
      02/06/20248:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/06/20244:56PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/05/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
      02/02/20245:04PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
      02/02/20248:00AMPR Newswire (US)Tyra Biosciences, Inc. Announces $200 Million Private Placement FinancingNASDAQ:TYRATyra Biosciences Inc
      02/01/20245:30PMPR Newswire (US)Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of AchondroplasiaNASDAQ:TYRATyra Biosciences Inc
      02/01/20245:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
      12/22/20239:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
      12/22/20239:00AMPR Newswire (US)Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300NASDAQ:TYRATyra Biosciences Inc
      11/08/20234:05PMPR Newswire (US)Tyra Biosciences to Participate in 2023 Jefferies London Healthcare ConferenceNASDAQ:TYRATyra Biosciences Inc
      11/07/20234:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TYRATyra Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:TYRA